Showing results (141-150 of 795) with videos related to
Sort By:
Pageof 80
Journal of Clinical Microbiology|July 1, 1993
Ramoplanin susceptibility testing criteriaA L Barry, M A Pfaller, P C FuchsAmerican Journal of Surgery|May 1, 1984
Antimicrobial prophylaxis in elective colon surgery. Experience of 1,035 operations in a community hospitalJ J Peck, P C Fuchs, M E GustafsonAnnals of Surgery|February 1, 1980
Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein graftsR L McCann, P O Hagen, J C FuchsJournal of Clinical Microbiology|January 1, 1997
Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC GroupP C Fuchs, A L Barry, S D BrownSurgery, Gynecology & Obstetrics|September 1, 1980
Surgical management of aortic abdominal aneurysms in patients with severe pulmonary insufficiencyP K Smith, J C Fuchs, D C SabistonThe Journal of Antimicrobial Chemotherapy|January 1, 1993
RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteriaM A Pfaller, A L Barry, P C FuchsDiagnostic Microbiology and Infectious Disease|April 1, 1996
Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance GroupP C Fuchs, A L Barry, S D BrownJournal of Oral Rehabilitation|May 1, 1985
Mandibular dysfunction in 10-18 year old school children as related to morphological malocclusionM A Lieberman, E Gazit, C Fuchs, et al.Antimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A PfallerThe Journal of Antimicrobial Chemotherapy|December 16, 1998
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresA L Barry, P C Fuchs, S D BrownPageof 80